MedTrace Logo

Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients

NCT04120870 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-03-03

No results posted yet for this study

Summary

In trauma patients with high shock index, the investigators compare the effects on hemodynamics between ketamine and etomidate.

Conditions

Interventions

DRUG

Etomidate Injection 0.2 mg/kg

The induction agent of rapid sequence intubation is etomidate. 0.2 mg/kg

DRUG

Ketamine injection 2 mg/kg

The induction agent of rapid sequence intubation is ketamine. 2 mg/kg

Sponsors & Collaborators

  • Unimedics (http://unimedics.co.kr)

    collaborator UNKNOWN

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • In Kyong Yi, MD · Ajou University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-11-30
Completion
2021-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04120870 on ClinicalTrials.gov